Regulation, Compliance & Legal › Sub-category

Licence / Approval / Cancellation

20 articles
Regulatory approvals and licensing activities are shaping the landscape for Indian financial and pharmaceutical companies. Several entities, including Mufin Green Finance, SG Finserve, Paytm Payments Services, and Fino Payments Bank, secured crucial licenses from the RBI, enabling expansion into foreign exchange, alternative investments, and digital payment services. Simultaneously, MSTC received TReDS authorization, while Wanbury and Smruthi Organics gained approvals from ANVISA, bolstering their presence in the Brazilian market. These developments signal a positive trend toward regulatory compliance and international expansion, potentially enhancing growth prospects for these businesses and reinforcing India's position as a key player in both financial and pharmaceutical sectors.
Biocon EU Pertuzumab Biosimilar Approval Under New Pathway
Biocon received European Commission marketing authorization for Pebrilzo®, its biosimilar pertuzumab, for HER2-positive breast cancer treatment. This is the first biosimilar approved under EMA's new t
Senores Subsidiary Ratnatris Receives PIC/S GMP Certification
Senores Pharmaceuticals subsidiary Ratnatris receives PIC/S GMP certification from Ukraine's State Service of Medicines and Drugs Control. Certification issued on November 16, 2026, and received by th
Glenmark's IGI Submits IND for ISB 2301 Cancer Drug
Ichnos Glenmark Innovation submitted an IND application to U.S. FDA for ISB 2301, a first-in-class multispecific immune cell activator targeting solid tumors. The pentaspecific molecule targets three
Mufin Green Finance Q2 FY27 AUM Up 71.8% YoY
Mufin Green Finance reported Q2 FY27 AUM of ₹1,766 crores, up 71.8% YoY, driven by a pivot to digital lending products. Net profit surged 148.5% YoY to approximately ₹29 crores for H1 FY27, with Gross
XTGlobal Infotech Receives RBI Approval for Ireland Investment
XTGlobal Infotech received RBI approval for EUR 10,000 equity investment in its Irish subsidiary. The investment represents initial capital contribution to XTG Infotech Europe Limited established in J
BSE BANKEX Futures Approved by US CFTC
BSE's BANKEX Index Futures contract receives CFTC approval for offer and sale to US investors. Approval enables US institutional investors to access Indian banking sector exposure through regulated de
Regal Entertainment Receives RBI Director Appointment Approval
Regal Entertainment received RBI approval for Satbir Singh's appointment as Executive Director effective November 16, 2026. The approval is valid for six months and requires subsequent shareholder app
Biocon Gets U.S. FDA Approval for Pebrilzo Biosimilar
Biocon Limited received U.S. FDA approval for Pebrilzo™ (pertuzumab-qcay), a biosimilar to Perjeta®, for HER2-positive breast cancer treatment. The approval strengthens Biocon's oncology portfolio to
Alembic Pharma USFDA Binimetinib Final Approval
Alembic Pharmaceuticals received USFDA final approval for its generic Binimetinib Tablets, 15 mg and 45 mg. The product has an estimated market size of US$282 million and the company is eligible for 1
Mach Travel Receives Uttar Pradesh Tourism Recognition Certificate
Mach Travel Solutions received a Recognition Certificate from Uttar Pradesh Tourism Department as a Category-1B Travel Agency. The certificate is valid for five years from October 30, 2026, acknowledg
Munoth Financial Services Surrenders SEBI Merchant Banker License
Munoth Financial Services Board approves voluntary surrender of its SEBI Category I Merchant Banker license. The surrender is a voluntary action by the company and not a cancellation or suspension by
Mufin Green Finance Receives RBI AD-II License
Mufin Green Finance received RBI Authorised Dealer Category-II license for foreign exchange activities. The license enables the company to undertake permissible foreign exchange transactions and servi
SG Finserve SEBI Approves Subsidiary AIF Registration
SG Finserve Limited discloses SEBI's approval for its wholly-owned subsidiary SG Alternative Investment Fund Limited to register SG Finserve Multistrategy Investment Trust as a Category III Alternativ
Paytm Payments Services Gets RBI In-Principle PPI Authorization
Paytm Payments Services Ltd receives RBI in-principle authorisation to issue and operate Prepaid Payment Instruments (wallets) in India. The authorisation is subject to a system and cyber security aud
Kuber Udyog Voluntarily Surrenders NBFC Registration
Kuber Udyog Ltd received RBI approval for voluntary surrender of its Non-Banking Financial Company (NBFC) registration, effective November 5, 2026. The company had ceased NBFC activities in May 2026,
Wanbury Receives ANVISA Approval for Metformin HCl API
Wanbury Limited received regulatory approval (CADIFA) from ANVISA for its flagship API product Metformin HCl EP grade. This marks the third consecutive ANVISA approval for Wanbury's APIs, enabling cus
Smruthi Organics Receives Brazilian GMP Certificate
Smruthi Organics received Brazilian GMP Certificate (CBPF) from ANVISA for its Unit II facility in Chincholi, Solapur. Certificate validates compliance for manufacturing Levanlodipine Besylate Hemipen
Sandur Manganese Receives Environmental Clearance for Mine Expansion
Sandur Manganese receives environmental clearance to increase iron ore production capacity from 7.85 MTPA to 9.42 MTPA. Manganese ore production capacity reduced from 1.34 MTPA to 0.7330 MTPA as part
Star Health IRDAI Approves HDFC MF 9.99% Stake Acquisition
IRDAI approved HDFC Mutual Fund schemes to acquire up to 9.99% equity stake in Star Health & Allied Insurance Company. The approval includes current investment of 4.49% and future acquisition up to th
CSB Bank RBI Approves ICICI Prudential 9.95% Stake
RBI grants ICICI Prudential AMC approval to acquire up to 9.95% stake in CSB Bank. Approval is subject to compliance with Banking Regulation Act and SEBI regulations. Disclosure made pursuant to SEBI